NEXT Financial Holdings’s Arbutus Biopharma ABUS Stock Holding History

NEXT Financial Holdings’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1K	Buy	+200	New	+$768	﹤0.01%	1529

Other funds holding ABUS

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

NEXT Financial Holdings's ABUS Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Arbutus Biopharma (ABUS) in Q1 2019: 200 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1529 among its holdings.

72 funds tracked by Wall St. Rank hold ABUS as of Q1 2019.

NEXT Financial Holdings held 200 shares of Arbutus Biopharma worth $1K as of Q1 2019.
Arbutus Biopharma was a new NEXT Financial Holdings position in Q1 2019.
Arbutus Biopharma made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1529 holding.
72 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.